Valeant sees 'unrivaled' growth in possible Allergan merger
(Reuters) - A merger between Valeant Pharmaceuticals International Inc (VRX.TO) and Allergan Inc (AGN.N) would create an "unrivaled platform for growth and value creation" in the healthcare sector, a spokesperson for Valeant said on Monday.
Valeant will finalize and announce terms of its proposal shortly, the spokesperson said.
(Reporting by Rod Nickel. Editing by Andre Grenon)
- Visa Inc, the world's largest credit and debit card company, reported an 11 percent rise in quarterly profit as more people around the world used plastic instead of cash to make purchases.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.